A detailed history of Golden State Equity Partners transactions in Pfizer Inc stock. As of the latest transaction made, Golden State Equity Partners holds 1,778 shares of PFE stock, worth $47,330. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,778
Previous 36,068 95.07%
Holding current value
$47,330
Previous $1.04 Million 95.11%
% of portfolio
0.03%
Previous 0.24%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$27.7 - $31.39 $949,833 - $1.08 Million
-34,290 Reduced 95.07%
1,778 $51,000
Q3 2024

Oct 25, 2024

BUY
$27.7 - $31.39 $999,083 - $1.13 Million
36,068 New
36,068 $1.04 Million
Q4 2023

Feb 02, 2024

BUY
$26.13 - $33.94 $381,680 - $495,761
14,607 Added 134.18%
25,493 $733,000
Q3 2023

Oct 20, 2023

BUY
$32.09 - $37.51 $5,647 - $6,601
176 Added 1.64%
10,886 $361,000
Q2 2023

Jul 19, 2023

SELL
$36.12 - $41.79 $175,434 - $202,974
-4,857 Reduced 31.2%
10,710 $392,000
Q1 2023

Jun 01, 2023

BUY
$39.39 - $51.28 $411,192 - $535,311
10,439 Added 203.57%
15,567 $635 Million
Q1 2022

May 18, 2022

SELL
$45.75 - $56.69 $43,279 - $53,628
-946 Reduced 15.57%
5,128 $265,000
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $611,494 - $757,718
-13,366 Reduced 68.76%
6,074 $220,000
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $18,841 - $27,930
456 Added 2.4%
19,440 $1.15 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $387,397 - $497,645
9,870 Added 108.29%
18,984 $817,000
Q2 2021

Aug 12, 2021

BUY
$35.91 - $40.68 $109,166 - $123,667
3,040 Added 50.05%
9,114 $357,000
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $15,673 - $17,676
-468 Reduced 7.15%
6,074 $220,000
Q4 2020

Feb 08, 2021

BUY
$33.47 - $42.56 $218,960 - $278,427
6,542 New
6,542 $240,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Golden State Equity Partners Portfolio

Follow Golden State Equity Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Equity Partners with notifications on news.